The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Sep 2016
Observational Study30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this indicator are limited. The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public Health England allows the assessment of factors affecting 30-day mortality in a national patient population. The aim of this first study based on the SACT dataset was to establish national 30-day mortality benchmarks for breast and lung cancer patients receiving SACT in England, and to start to identify where patient care could be improved. ⋯ Public Health England.